Thyroid cancer diagnosis prognostic marker MAPK8IP1P2 and application thereof
A technology for thyroid cancer, use, applied in the field of biomedicine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment example 1
[0053] Experimental example 1. MAPK8IP1P2 is down-regulated in thyroid cancer tissue, and in the thyroid cancer group with lymph node metastasis The down-regulation in weaving is more obvious
[0054] Such as figure 1 As shown, MAPK8IP1P2 was significantly down-regulated in cancer tissues (8 / 10 cases were downregulated, figure 1 A), further expanding the sample size, it was verified that MAPK8IP1P2 was significantly down-regulated in cancer tissues compared to paracancerous control tissues (ANT in the figure) and benign lesion tissues (Beign in the figure) ( figure 1 B), Interestingly, the downregulation of MAPK8IP1P2 was more significant in the cancer tissues with lymph node metastasis (shown pN1) compared with the cancer tissues without lymph node metastasis (shown pN0) ( figure 1C). The above results show that detecting the level of MAPK8IP1P2 can not only identify whether thyroid cancer is present, but also can distinguish whether thyroid cancer patients have lymph...
experiment example 2
[0055] Experimental example 2. Down-regulation of MAPK8IP1P2 predicts poor prognosis in patients with thyroid cancer
[0056] According to the median expression level of MAPK8IP1P2, the relationship between the expression level of MAPK8IP1P2 and prognosis was further analyzed. The results are as follows: figure 2 As shown, the progression-free survival time of patients in the low expression group was significantly shorter than that in the high expression group, indicating that MAPK8IP1P2 is down-regulated in thyroid cancer tissues and predicts poor prognosis of patients. It can be seen that detecting the level of MAPK8IP1P2 can predict the survival prognosis of patients with thyroid cancer.
experiment example 3
[0057] Experimental example 3. Overexpression of MAPK8IP1P2 can inhibit the tumorigenesis of thyroid cancer cells in vivo
[0058] In B-CPAP and K1 thyroid cancer cells, cell models stably expressing MAPK8IP1P2 and silencing MAPK8IP1P2 were constructed using lentivirus, such as image 3 As shown, cells stably expressing MAPK8IP1P2 were able to up-regulate MAPK8IP1P2, while cells silenced for MAPK8IP1P2 (shown as sh#1) were able to down-regulate MAPK8IP1P2 compared to the respective control vectors. Using the subcutaneous xenograft tumor model in nude mice, we detected the tumorigenesis of K1 cells in vivo, and observed that overexpression of MAPK8IP1P2 in thyroid cancer cells can inhibit the size of tumor formation in vivo, while silencing promotes ( Figure 4 A), analyzing the tumor and growth curve of transplanted tumors, it is also clear that overexpression of MAPK8IP1P2 in thyroid cancer cells can inhibit its tumorigenicity in vivo, while silencing can promote ( Figure...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com